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Abstract
Migraine patients frequently report cognitive difficulties in the proximity and during migraine attacks. We performed an
exploratory comparison of executive functioning across the four stages of the migraine cycle. Consecutive patients with
episodic migraine undertook cognitive tests for attention, processing speed, set-shifting, and inhibitory control. Per-
formance was compared between patients in different migraine stages, controlling for attack frequency and prophylactic
medication. One hundred forty-three patients (142 women, average age 36.2 + 9.9 years) were included, 28 preictal
(48 h before the attack), 21 ictal (during the attack), 18 postictal (24 h after attack), and 76 interictal. Test per-
formance (age and literacy adjusted z-scores) was not significantly different across migraine phases, despite a tendency
for a decline before the attack. This negative study shows that cognitive performance fluctuates as patients approach
the attack. To control for individual variability, this comparison needs to be better characterized longitudinally with a
within-patient design.
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Introduction
Migraine is a cyclic brain disorder characterized by recur-
ring attacks of headache, intolerance to sensory stimuli
and autonomic dysfunction.1 The attacks are preceded and
followed by brain changes, documented in functional
brain imaging and neurophysiological measures, which
involve sensory processing and autonomic and cognitive
functioning.2–4 These phenomena have been conceptua-
lized to cycle within four distinctive phases: premonitory
(preictal), ictal, resolution (postictal), and interictal.
Cognitive difficulties are commonly reported in all
active phases of migraine. During attacks, patients describe
an inability to focus or think properly, they feel mentally
slow and have difficulty in carrying more than one task
simultaneously, which makes cognitive impairment to rank
second, after pain, among the causes of attack-related dis-
ability.5 Likewise, in the preictal and postictal phases,
patients often report poor concentration, irritability, and
difficulty in oral and written speech.5 These descriptions
suggest that migraine attacks are associated with a rever-
sible disorder of attention and executive functions, which
have been supported by neuropsychological evaluations
performed during the attacks.6 However, there are no sys-
tematic studies, assessing cognitive performance during the
other phases of migraine. The aim of this study was to
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perform a prospective exploratory evaluation of the exec-
utive functioning of migraine patients observed in different
phases of the attack. Our hypothesis was that patients
would have a worse performance on the preictal and ictal
phases compared to the interictal period.
Methods
This is a prospective, cross-sectional, observational study
of patients with episodic migraine, assessed during differ-
ent phases of migraine cycle. Patients were recruited in a
Headache Outpatient Clinic of a University Hospital, dur-
ing a scheduled medical appointment, after agreement and
signing the informed consent.
Adult patients aged between 18 years and 60 years, with
episodic migraine with or without aura fulling the Interna-
tional Classification of Headache Disorders-III criteria,1
were invited to participate. Exclusion criteria were (a) a
diagnosis of major depression or other psychiatric disorder;
(b) illiteracy; (c) history of other neurologic disorders (e.g.
stroke, head trauma, epilepsy, etc.) or developmental delay;
and (d) pregnancy, in the case of female patients. The study
protocol was approved by the Lisbon Academic Medical
Center Ethics Committees.
Procedures
Demographic and clinical data were collected through a
semistructured interview and the analysis of patients’
calendars. Data included present age, age at migraine onset,
current attack frequency (<1, 1–3, and >3 attacks per
month), average attack duration (<24 h, 24–48 h, and
48 h), average headache intensity (mild, moderate, and
severe), pain type and location, current prophylactic treat-
ment (in particular, antiepileptic medication), and a family
history of migraine. Females in child-bearing age were
asked if they were menstruating at the time of evaluation.
Patients undertook a brief cognitive evaluation per-
formed by a psychologist or a trained medical student
immediately after the appointment. This assessment com-
prised tests tackling sustained attention and processing
speed (digit symbol subtest from the Wechsler Adult Intel-
ligence Scale—III),7 divided attention/set-shifting (trail
making tests A, B, and B-A),8 and selective attention/inhi-
bitory control (stroop interference test).9 Individual scores
were converted to age and education adjusted z-scores
according to the existing norms.10,11
Patient’s migraine status
Date and time of cognitive testing and time since the last
attack were recorded. Patients were contacted by telephone
48 h after the evaluation to check for new attacks. Time of
assessment during the migraine cycle was then categorized
into four stages: (a) preictal (assessment took place within
48 h before the onset of an attack), (b) ictal (during reported
attack), (c) postictal (within the first 24 h following an
attack), and (d) interictal (none of previous).
End points and statistical analysis
Statistical analysis was performed with the SPSS 25.0.
Descriptive statistics of mean and standard deviation were
obtained for continuous variables, and counts and frequen-
cies for categorical variables. Group differences were
tested using a one-way analysis of variance for continuous
variables or w2 test for categorical variables. A multivariate
analysis of covariance (ANCOVA) was performed with
cognitive performance as the dependent variable and
migraine cycle phase as the independent variable. Attack
frequency and the use of prophylactics were entered in the
model as covariates. Statistical significant differences
between groups were analyzed with Bonferroni post
hoc test. Results were considered statistically significant
at p < 0.05. The sample size was calculated for primary
outcome (Stroop words, trail making test (TMT) A) based
on a report on cognitive performance during and between
attacks,6 assuming a level of significance of 95%, an 80%
power, and an allocation ratio of 3/2. For Stroop Words, we
estimated a sample size of 73 (44 in interictal and 29 in
perictal) to detect a difference of 13 words between the
two groups. For TMT A, we estimated a sample size of
163 (98 in interictal and 65 in perictal) to detect a differ-
ence of 6.8 s between the two groups.
Results
A total of 143 patients were included, 142 (99.3%) were
women, with an age average of 36.2 years (+9.9 years,
ranging between 18 years and 56 years). Migraine features
are depicted in Table 1. Since there were some missing data
that could not be collected or did not apply to all subjects
(for instance, the menstrual period), Table 1 also presents
the number of subjects that were eligible for the analyses of
each variable. Patients were more frequently observed in
the interictal phase (53.7%), followed by the preictal
(19.6%), ictal (14.7%), and the postictal phases (12.6%).
Most patients were under prophylactic treatment, 16 taking
antiepileptic medication. There were no significant differ-
ences in patients’ demographic or clinical features between
phases. Twelve patients were observed during menstrua-
tion with a similar frequency across the four phases.
Patients’ test scores were, on average, within normal
range (i.e. between 0.5 and þ0.5 on age and education
adjusted z-scores; Table 1). Cognitive performance was not
statistically different between phases, although some trends
could be identified (Figure 1), namely a preictal decline on
Stroop Color Naming and interference and TMT A and B
(measures of inhibitory control and divided attention), a
worse performance on TMT BA on the postictal phase
(measuring attention shift), and a decline on Digit Symbol
in the ictal phase (measuring processing speed). No
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significant differences were found when the interictal
scores were compared with all other migraine phases.
Moreover, no differences were found on the multivariate
ANCOVA controlling for attack frequency and prophylac-
tic medication (Table 2).
Discussion
In this exploratory study, we observed minor fluctuations in
cognitive test performance between the four migraine
phases, but we were unable to document significant differ-
ences across the stages even when the three peri-ictal
phases were aggregated and compared with the interictal
period. This is, therefore, a negative study that contrasts
with previous reports, in which repeated measures of the
same participants showed a significant decrease in process-
ing speed and memory during the attacks, compared to
interictal phase.6
We interpret these negative results due to several fac-
tors. The first is related to individual variability both on
baseline functioning (interictal phase) and attack-related
impairment. Although we found no differences between
groups on demographic and literacy variables (which are
strong predictors of cognitive performance), we did not
measure their cognitive background or IQ, which might
have allowed to correct intersubject variability and reduce
group differences. On the other hand, migraine is known as
a highly individualized disorder with a variability of the
attacks within and between subjects. Within-patient differ-
ences have been documented in cognitive, imaging, and
neurophysiological studies with smaller samples of patients
but using within-subjects comparisons.2,3,6 A longitudinal
study, with a within-patient design, is, therefore, more ade-
quate to investigate this question controlling for individual
variations.
Secondly, changes observed were minor since, on aver-
age, all the results obtained in the four migraine phases
Table 1. Sample’s demographic, clinical, and cognitive data.
Total Interictal Preictal Ictal Postictal Statisticsa p Value
Patients’ characteristics
N 143 76 28 21 18 — —
Gender (female:male) 142:1 75:1 28:0 21:0 18:0 0.888 0.828
Current ageb (years; mean (SD)) 36.2 (9.9) 34.7 (9.7) 38.7 (8.6) 37.6 (10.2) 35.6 (11.2) 1.326 0.268
Age at migraine onsetb (years; mean (SD)) 17.9 (8.5) 18.7 (9.0) 16.8 (7.4) 16.0 (6.1) 19.2 (9.6) 0.874 0.456
Educationb (years; mean (SD)) 13.1 (3.5) 13.1 (3.6) 12.8 (3.7) 12.2 (3.4) 14.9 (2.7) 2.257 0.084
Family historyc (yes:no) 79:39 38:20 17:11 13:7 11:1 3.893 0.273
Attack frequencyd (<1 x/m:1–3 x/m; 4x/m) 9:60:68 7:33:32 2:8:17 0:8:12 0:11:7 9.588 0.385
Attack duratione (<24 h:24–48 h:>48 h) 31:71:39 18:37:20 2:19:7 5:9:6 6:6:6 8.272 0.507
Pain localizationb
(unilateral:bilateral:variable)
84:40:19 44:20:11 15:9:4 14:6:1 11:4:3 2.213 0.899
Pain typeb (pulsatile:pressure:other) 82:48:13 46:26:3 19:8:1 8:9:4 9:5:4 12.577 0.050
Pain severityf (mild:moderate:severe) 3:53:87 2:32:42 0:5:23 1:6:14 0:10:8 11.041 0.087
Auraf (yes:no) 54:89 27:49 10:18 12:9 5:13 4.485 0.214
Prophylatic treatmentb (yes:no) 74:69 35:41 16:12 13:8 10:8 2.286 0.515
Menstruationg (yes:no) 11:29 4:6 6:19 1:4 0:0 1.078 0.583
Time between last attack and assessmenth
(days; mean (SD))
10.7 (23.2) 14.1 (29.4) 14.5 (14.3) 0.1 (0.2) 1.0 (0.0) 2.068 0.110
Cognitive performance
Digit symbole (z-score; mean(SD)) 0.4 (0.8) 0.5 (0.9) 0.3 (0.8) 0.5 (0.8) 0.4 (0.7) 0.548 0.650
Stroop Wb (z-score; mean(SD)) 0.1 (0.6) 0.1 (0.5) 0.01 (0.4) 0.03 (0.6) 0.02 (0.7) 0.442 0.723
Stroop Cb (z-score; mean(SD)) 0.2 (0.6) 0.1 (0.5) 0.2 (0.6) 0.1 (0.6) 0.03 (0.6) 0.244 0.866
Stroop CWb (z-score; mean(SD)) 0.2 (0.8) 0.1 (0.6) 0.3 (0.8) 0.1 (0.7) 0.1 (0.9) 0.707 0.549
TMT Ab (z-score; mean(SD)) 0.3 (1.1) 0.4 (1.2) 0.1 (0.8) 0.3 (0.9) 0.5 (1.4) 0.618 0.605
TMT Bb (z-score; mean(SD)] 0.1 (1.2) 0.03 (1.4) 0.01 (1.1) 0.01 (1.0) 0.4 (0.8) 0.484 0.694
TMT BAb (z-score; mean(SD)) 0.2 (1.1) 0.3 (0.8) 0.02 (1.1) 0.01 (2.0) 0.4 (0.8) 1.027 0.383
m: months; SD: standard deviation; stroop C: stroop color naming; stroop CW: stroop interference; stroop W: stroop reading; TMT A: trail making test
part A; TMT B: trail making test part B; ANOVA: analysis of variance.
aOne-way ANOVA (continuous variables) or w2 test (categorical variables); significance set at p < 0.05.
bEligible cases for analyses are indicated for each variable: n ¼ 143.
cEligible cases for analyses are indicated for each variable: n ¼ 118.
dEligible cases for analyses are indicated for each variable: n ¼ 137.
eEligible cases for analyses are indicated for each variable: n ¼ 141.
fEligible cases for analyses are indicated for each variable: n ¼ 142.
gEligible cases for analyses are indicated for each variable: n ¼ 40.
hEligible cases for analyses are indicated for each variable: n ¼ 91.
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were within normal range. This may indicate that the tests
used may not have sufficient sensitivity to document the
changes that are perceived by the patients and may impair
their performance in more complex and demanding activ-
ities of work or daily living. Thirdly, migraine affects
mostly women, and there is some evidence that cognitive
performance fluctuates along the menstrual cycle, with a
worse performance in the luteal phase12 and that brain
connectivity changes in relation with the menstrual phase
in natural cycles.13 However, given that in this study, we
included women on contraception, postmenopausal, and
women in different phases of the cycle, and it is difficult
to contemplate this information in the analysis. Neverthe-
less, we included the presence of menstrual period during
assessment, an occasion where migraine attacks tend to
cluster, but this had no impact on performance.
Finally, it is known that frequent attacks and chronic
migraine are more frequently associated with cognitive
changes14,15 than episodic infrequent migraine, which
could explain the lack of significant changes found on the
present sample, in which most patients had one to three
attacks per month.
We acknowledge other limitations and confounders that
need to be addressed in future studies, in addition to the
questions concerning the study design. One is the differ-
ence of sample sizes between groups of patients within
each migraine phase. For instance, the higher interictal
group size reported herein can be explained by the fact that
episodic migraine diagnosis, by definition, includes
patients that have migraine less than 15 days per month,
which suggests that the odds of screening/recruiting
patients in other phases is lower. Secondly, the necessary
sample size varied among cognitive tests, which may have
impaired significance on some of the measures used.
Furthermore, we compared group averages, a method with
less statistical power than within-subject comparisons.
Finally, and based on previous findings, we restricted the
cognitive evaluation to our initial hypothesis of an expected
decline in executive functioning and did not test for memory,
fluency, vocabulary, or other cognitive functions. Besides,
tests used were designed to diagnose cognitive impairment
and may lack sensitivity when looking for mild fluctuations.
Yet, all have a good test–retest reliability (ranging from 0.71
to 0.91).16–18 It is possible that more cognitively demanding
tasks, such as those with computerized reaction time, sus-
tained periods of attention, verbal fluency, or demanding
memory tasks, more similar to the abilities required to work,
are more significantly affected in the peri-ictal period.
Taken together, these factors may have contributed to
the negative results obtained and limited their interpreta-
tion, underlining the need for longitudinal studies with a
within-subject design.
Clinical implications
 Patients with migraine experience cognitive difficul-
ties during and on the vicinity of migraine attacks
that contribute to attack-related disability.
 We evaluated 143 patients in different phases of
migraine with cognitive tests and could not find an
Figure 1. Cognitive performance across migraine cycle phases.
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objective decline in cognitive performance between
the interictal phase and the ictal or peri-ictal periods,
which can be due to patients’ and attack variability.
 Longitudinal studies comparing cognitive perfor-
mance within the same subject along the migraine
cycle are warranted to clarify this question.
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